Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Industry News
Share your love
Dry Eye Treatment & Cyclosporine and Side Effect in Dogs
Dry eye disease (DED), also known as keratoconjunctivitis sicca (KCS), is a common disorder of the eye affecting millions of people around the world. The prevalence of DED ranges from 5% to 33% worldwide with increased prevalence among adult women…
ESCRS 2023 Recap: Biotech Companies That Stand Out
As OBN, we had the privilege of participating in the ESCRS Congress 2023 held in Vienna, where we witnessed the remarkable efforts of various companies dedicated to enhancing patient outcomes. In this exclusive article, we present a compilation of ten…
What Is Corneal Collagen Cross-Linking?
The world of ophthalmology is constantly evolving, with innovative treatments and procedures emerging to address a wide range of eye conditions. One such cutting-edge treatment, corneal collagen cross-linking (CXL), has gained significant attention for its role in managing keratoconus, a…
FDA Warns Against Infection Risks from Copycat Eye Drops
The U.S. Food and Drug Administration (FDA) is warning consumers against the purchase and use of South Moon, Rebright, or FivFivGo eye drops due to the potential risk of eye infection. These products, identified as copycats, pose a danger as…
Lotilaner Shows Promise for Treating Demodex Blepharitis
A team of investigators, led by Elizabeth Yeu, MD, from Virginia Eye Consultants in Norfolk, Virginia, reported the safety and efficacy of lotilaner ophthalmic solution, 0.25% (TP-03, Tarsus Pharmaceuticals Inc.), in treating Demodex blepharitis. Demodex mites are the most common…
Roche Halts Development of Diabetic Retinopathy Drug
Swiss-based pharmaceutical company Roche has announced the discontinuation of its oral diabetic retinopathy treatment, vicasinabin, after successfully completing Phase II clinical trials. In a recent presentation to investors, Roche confirmed its decision to halt further investment in vicasinabin, a promising…
Researchers Develop Game-Changing Eye Drops for DME
After 30 years of dedicated work, two researchers have achieved a remarkable breakthrough by developing eye drops that can effectively reach the back of the eye. This groundbreaking development paves the way for needle-free treatments of blinding retinal diseases, such…
Vyjuvek Restores Vision in Teen with Rare Genetic Condition
Krystal Biotech’s topical gene therapy Vyjuvek (beremagene-geperpavec) has successfully restored the vision of a 13-year-old boy suffering from the rare genetic condition dystrophic epidermolysis bullosa (DEB), which scarred his eyes. The groundbreaking case, detailed in a recent publication in The…
Eyenovia’s Redwood City Facility Clears FDA Inspection
Eyenovia announced the successful completion of the FDA inspection for its facility in Redwood City, California, marking a significant milestone in the company’s manufacturing capabilities. This achievement signals the green light for the facility to engage in final assembly, packaging,…
Novel Protocol to Rapidly Diagnose Eye Stroke
Ophthalmologists at New York Eye and Ear Infirmary of Mount Sinai (NYEE) have pioneered a novel protocol aimed at swiftly diagnosing eye stroke and expediting care to prevent irreversible vision loss. Published in Ophthalmology, their study outlines the use of…